Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.10.24
2019年公开发行公司债券（第一期）信用评级报告
2019.10.15
2019年前三季度业绩预告
2019.10.09
关于参股公司新药临床试验进展的提示性公告
2019.09.27
关于“16海普瑞”回售申报情况的公告
2019.09.24
关于“16海普瑞”票面利率调整暨投资者回售实施办法第三次提示性公告
2019.09.23
关于“16海普瑞”票面利率调整暨投资者回售实施办法第二次提示性公告
2019.09.20
关于“16海普瑞”票面利率调整暨投资者回售实施办法第一次提示性公告
2019.09.16
2019年第三次临时股东大会决议公告
2019.09.16
2019年第三次临时股东大会的法律意见书
2019.08.29
关于参加2019年深圳上市公司投资者网上集体接待日活动的公告
第一页
上一页
43
44
45
46
47
下一页
最后一页
